Budget Pressures And Rollout Delays Will Constrain Sleep Healthcare Prospects
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
28 Apr 25
Updated
20 Aug 25
AnalystLowTarget's Fair Value
US$97.00
1.0% undervalued intrinsic discount20 Aug
US$95.99
1Y
-49.2%7D
8.7%